Connect with us

Technology

West Monroe Acquires Inspired Health to Add Market Research and Insights Capabilities in Life Sciences Sector, Establishes New Boston Office

Published

on

Acquisition increases firm revenue in life sciences by 30% and enhances support for private equity amid rising investment

CHICAGO, Dec. 20, 2024 /PRNewswire/ — West Monroe, a global business and technology consulting firm, today announced it has acquired Inspired Health, a Boston-based market insights and commercial strategy consultancy serving life sciences clients. The acquisition expands West Monroe’s life sciences capabilities, grows its team, and adds a Boston office—bringing the firm’s global footprint to 11 locations.

Founded in 2017, Inspired Health helps pharmaceutical and medical device companies bring new products to market. The team supports key stages of the product lifecycle—including pre-launch, launch, and post-launch optimization—by providing insights into the needs of physicians, patients, administrators, and payers.

The acquisition significantly bolsters West Monroe’s life sciences practice and increases the firm’s revenue in the sector by 30%. It also brings on experienced industry leaders Kieron Mathews and Andrew Wilson as managing directors in the firm. A two-time CEO, Mathews has a career that spans two decades in market research and has been recognized by the Market Research Society as one of the industry’s Top 50 professionals. Wilson is a co-founder of Inspired Health and has also spent more than 20 years in the research industry.

Inspired Health adds deep expertise in the front-office segment of the life sciences value chain, complementing West Monroe’s strengths in back-office operations, technology, and patient services programs. Together, the combined teams will deliver comprehensive, end-to-end solutions for pharmaceutical and medical device companies. It also expands West Monroe’s capacity to support private equity clients amid rising deal volume in the pharma services and life sciences sector. The firm’s award-winning M&A team advises on 500-plus transactions each year, with healthcare as one of the top subsectors for investors.

“We are thrilled to welcome the talented team from Inspired Health,” said Kevin McCarty, Chairman & CEO of West Monroe. “Their data-based approach to client delivery and deep industry expertise is a strong match for our firm. This will create immediate value to our collective client base and will accelerate growth for our combined teams. I am also excited to formalize a West Monroe office in Boston, where we have significant and longstanding relationships with clients. We look forward to growing our presence in the Boston community.”

As part of the integration, West Monroe will retain Inspired Health’s Boston office at 2 Liberty Square, establishing West Monroe’s formal presence in the city. For over a decade, the firm has collaborated with Fortune 500 companies and top private equity clients in the Greater Boston area. This new physical presence enhances accessibility and broadens West Monroe’s ability to serve healthcare, private equity, and other industries in the region.

The transaction marks another step in West Monroe’s strategic expansion. The integration is expected to be complete in the first half of 2025.

About West Monroe
West Monroe is a global business and technology consulting firm passionate about creating value for our clients. We co-create solutions that accelerate results now and prepare industries to tackle what’s next. We’re excited by the possibilities that technology creates. We work with our clients to deliver on the possible, building on their goals, generating fresh insights and creating inspiring outcomes.

We excel at the intersection of industry, strategy, people and technology—always driving rapid impact. Our all-in approach comes from our unique employee ownership structure. Our clients’ success is our success. From the beginning, our growth has come from putting people at the center. Fortune and USA Today consistently celebrate West Monroe as a top workplace, and we’re recognized as a leading consultancy by Forbes and Forrester. Let’s find more value for your business.

Share our passion at westmonroe.com.

Media Inquiries
Christina Galoozis
Director, Communications & Public Relations
cgaloozis@westmonroe.com
847-302-1762

Shira Cohen
Manager, Public Relations
scohen@westmonroe.com
443-841-6879

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/west-monroe-acquires-inspired-health-to-add-market-research-and-insights-capabilities-in-life-sciences-sector-establishes-new-boston-office-302336954.html

SOURCE West Monroe Partners

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

IGCS International Announces Strategic Equity Investment by Lacks Enterprises

Published

on

By

DALLAS, April 22, 2026 /PRNewswire/ — IGCS International, a CVE-certified SDVOSB and leading provider of mission support and MRO supplies to the U.S. Department of Defense and federal agencies, today announced that Lacks Enterprises has acquired an equity stake in the company.

The strategic investment combines IGCS’s expertise in government supply chain, logistics, and MRO solutions with Lacks Enterprises’ advanced manufacturing capabilities, including electroplating, injection molding, composites, and testing for aerospace and defense.

“IGCS has built a strong track record supporting the Department of Defense… Partnering with Lacks Enterprises allows us to integrate cutting-edge manufacturing innovation into our offerings,” said Russ Spears, President of IGCS International.

Media Contact: Russ Spears, 214-733-7278, russ@igcsintl.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/igcs-international-announces-strategic-equity-investment-by-lacks-enterprises-302750824.html

SOURCE IGCS International

Continue Reading

Technology

Shoulder Innovations to Report First Quarter 2026 Financial Results on May 13, 2026

Published

on

By

GRAND RAPIDS, Mich., April 22, 2026 /PRNewswire/ — Shoulder Innovations, Inc. (“Shoulder Innovations”) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the first quarter of 2026 after market close on Wednesday, May 13, 2026.

Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on May 13, 2026. Those interested in listening to the conference call may do so by dialing (877) 407-8216 for domestic callers or (412) 902-1015 for international callers and providing access code 13759613. A live and archived webcast of the event will be available in the “Investor Relations” section of the Shoulder Innovations website at https://ir.shoulderinnovations.com/.

About Shoulder Innovations
Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a current offering of advanced implant systems for shoulder arthroplasty. These systems are a core element of Shoulder Innovations’ ecosystem, which is designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Shoulder Innovations’ ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care.

Contact
Brian Johnston or Sam Bentzinger 
Gilmartin Group LLC 
ir@shoulderinnovations.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/shoulder-innovations-to-report-first-quarter-2026-financial-results-on-may-13-2026-302750154.html

SOURCE Shoulder Innovations

Continue Reading

Technology

Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026

Published

on

By

MADISON, Wis., April 22, 2026 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2026, ended March 31, 2026, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on May 6, 2026.

The conference call dial-in numbers are 1-833-316-0563 (USA) or 1-412-317-5747 (international). In addition, a dial-up replay of the conference call will be available approximately one hour after the call’s conclusion for one week. The replay number is 1-855-669-9658 (USA) or 1-412-317-0088 (international), conference ID: 4178502.

A live webcast of the call will also be available from the Investor Relations section of the company’s website at investors.accuray.com. A webcast replay can be accessed on the website and will remain available until Accuray announces its results for the fourth quarter of fiscal 2026.

About Accuray
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Madison, Wisconsin, with facilities worldwide. To learn more, visit www.accuray.com or follow us on Facebook, LinkedIn, X, and YouTube.

Investor and Media Contact
Steve Monroe
VP, Financial Planning & Analysis, Accuray
Investor.relations@accuray.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-to-report-third-quarter-fiscal-2026-financial-results-on-may-6-2026-302750641.html

SOURCE Accuray Incorporated

Continue Reading

Trending